TokenPost·
Prelude Therapeutics Posts $5.6 Million in Q3 Revenue as Net Loss Narrows

Revenue fell 13% year over year, while net loss narrowed 36% to $12.5 million. The company expects its cash runway to extend into the second quarter of 2028.
Every crypto headline. One feed. Updated every minute.

Revenue fell 13% year over year, while net loss narrowed 36% to $12.5 million. The company expects its cash runway to extend into the second quarter of 2028.